U.S. and EU regulators urge Indian drug companies to step up standards savita thakur thakur25 Feb 2016 2:59 PM ISTU.S. and EU drug regulators called upon Indian drug companies to step up efforts to improve manufacturing standards and ensure the reliability of data...
Cipla launches generic hepatitis C drug Hepcvir-L in India savita thakur thakur25 Feb 2016 2:00 PM ISTNew Delhi: Drug major Cipla has launched generic tablets used for treating of hepatitis C under the brand name 'Hepcvir-L' costing Rs 25,000 for a...
Glenmark gets USFDA nod for contraceptive tablets savita thakur thakur25 Feb 2016 1:13 PM ISTNew Delhi: Glenmark Pharmaceuticals has received the final nod from the US health regulator for generic oral contraceptive norgestimate ethinyl...
FDA Approval granted to Zydus Cadilla for Ahemdabad Plant Meghna A Singhania24 Feb 2016 4:31 PM ISTZydus Cadilla has announced its return to the US business market . Cadilla’s U.S. business was closed down in 2014, when the company was caught for...
Fast acting anti-rabies drug set for an India launch savita thakur thakur24 Feb 2016 1:27 PM ISTAn instantly activated drug, in other words a fast acting anti-rabies drug to rapidly deactivate the rabies virus is soon to be launched in India. It...
ViiV Healthcare Acquires Bristol-Myers Squibbs R&D HIV Assets savita thakur thakur23 Feb 2016 5:02 PM ISTGlaxoSmithKline PLC has announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi ...
Aurobindo Pharma gets USFDA nod for Levofloxacin injection savita thakur thakur12 Feb 2016 8:15 AM ISTNew Delhi: Aurobindo Pharma said it has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market...
Natco Pharma Q3 net profit rises over two-fold to Rs 37.15 cr savita thakur thakur12 Feb 2016 8:11 AM ISTNew Delhi: Drug firm Natco Pharma reported over two-fold jump in consolidated net profit at Rs 37.15 crore for the third quarter ended December...
Imprimis Pharma to make cheaper alternative to Retrophin's Thiola savita thakur thakur11 Feb 2016 12:42 PM ISTCompounding pharmacy Imprimis Pharmaceuticals Inc said, it plans to make a cheaper alternative to Retrophin Inc's kidney stone drug, Thiola.Retrophin,...
FDA panel backs lower-cost version of J&J's top-selling drug savita thakur thakur11 Feb 2016 11:39 AM ISTWashington: Federal health advisers have endorsed a lower-cost version of Johnson & Johnson's blockbuster drug Remicade, a pricey biotech medicine...
FDA rejects expanded use of Vertex cystic fibrosis drug savita thakur thakur8 Feb 2016 1:22 PM ISTThe U.S. Food and Drug Administration has denied the expanded use of Vertex Pharmaceutical Inc's bestseller, Kalydeco, in certain cystic fibrosis...
GlaxoSmithKline posts loss of 428 million pounds as it integrates new businesses savita thakur thakur5 Feb 2016 11:24 AM ISTLondon: British-based drugmaker GlaxoSmithKline posted a loss of 428 million pounds for the fourth quarter of 2015 compared with a profit of over 1...
